Back

Pericardial fat volume outperforms classic risk markers in the prediction of relapse after pulmonary vein isolation

1 September 2019 (09:00 - 09:15)
Organised by:
Congress Presentation Part of: Novelties in atrial fibrillation and flutter management Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Joao Carmo

Hospital de Santa Cruz, Carnaxide (Portugal)

5 More presentations in this session

Presentation thumbnail
The incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
Mrs M. Jacobs (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Typical atrial flutter is a manifestation of previously silent coronary artery disease
Mr L. Iden (Bad Segeberg, DE)
Abstract Slides Video
Presentation thumbnail
Zero-fluoroscopy catheter ablation of right- and left-sided supraventricular tachycardias
Doctor M. Jan (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation
Doctor C. Schmidt (Goettingen, DE)
Abstract
Presentation thumbnail
Pulsed Field Ablation: Acute and Chronic Safety and Lesion Efficacy
Doctor A. Verma (Montreal, CA)
Abstract

Access the full session

Session thumbnail
Novelties in atrial fibrillation and flutter management

The Event

Event poster

ESC Congress 2019

1 September 2019 09:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources